News for Zynerba Pharmaceuticals, Inc. (0M40.L)

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.

Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.

Item 2.01. Completion of Acquisition or Disposition of Assets. On October 10, 2023, Harmony Biosciences...

In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.

DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced...

DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders,

On September 13, 2023, President Terri Sebree of Zynerba Pharmaceuticals Inc (ZYNE) sold 12,401 shares of the company's stock. This move comes amidst a yea

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

/PRNewswire/ -- The autism spectrum disorder therapeutics market is set to grow by USD 772.65 million from 2022 to 2027, progressing at a CAGR of 7.2% during...

BALA CYNWYD, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...